Jansen metaphyseal chondrodysplasia: analysis of craniofacial manifestations

被引:0
|
作者
Obiezu, Fiona [1 ]
Almpani, Konstantinia [2 ]
Kim, Hung Jeffrey [3 ]
Zalewski, Christopher [3 ]
Chu, Emily [4 ]
Jahanmir, Golnar [5 ]
Roszko, Kelly L. [1 ]
Boyce, Alison [6 ]
Farhadi, Faraz [7 ]
Weinstein, Lee S. [8 ]
Gafni, Rachel, I [1 ]
Ferreira, Carlos R. [9 ]
Juppner, Harald [10 ,11 ]
Collins, Michael T. [1 ]
Lee, Janice S. [2 ]
Jha, Smita [7 ,8 ]
机构
[1] Natl Inst Dent & Craniofacial Res, Skeletal Disorders & Mineral Homeostasis Sect, NIH, Bethesda, MD 20892 USA
[2] Natl Inst Dent & Craniofacial Res, Craniofacial Anomalies & Bone Regenerat Sect, NIH, Bethesda, MD USA
[3] Natl Inst Deafness & Other Commun Disorders, Audiol Unit, NIH, Bethesda, MD 20892 USA
[4] Univ Maryland, Sch Dent, Sch Dent, Baltimore, MD 21201 USA
[5] Natl Inst Dent & Craniofacial Res, NIH Dent Clin, NIH, Bethesda, MD 20892 USA
[6] Natl Inst Dent & Craniofacial Res, NIH, Metab Bone Disorders Unit, Bethesda, MD 20892 USA
[7] NIH, Clin Ctr, Radiol & Imaging Sci, Bethesda, MD 20892 USA
[8] Natl Inst Diabet & Digest & Kidney Dis, Metab Dis Branch, NIH, Bethesda, MD 20892 USA
[9] Natl Human Genome Res Inst, Skeletal Genom Unit, NIH, Bethesda, MD 20892 USA
[10] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[11] Harvard Med Sch, Boston, MA 02114 USA
关键词
parathyroid hormone receptor; Pth1r; Pth1r activation; Pth1r signaling; temporal bone and hearing in jansen; neurocristopathy; airway in jansen; dentition in jansen; SIGNALING PATHWAYS; RECEPTOR; MUTATIONS; INSIGHTS;
D O I
10.1093/jbmrpl/ziae156
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Jansen metaphyseal chondrodysplasia (JMC) is an ultra-rare disorder caused by constitutive activation of parathyroid hormone type 1 receptor (PTH1R). We sought to characterize the craniofacial phenotype of patients with the disease. Six patients with genetically confirmed JMC underwent comprehensive craniofacial phenotyping revealing a distinct facial appearance that prompted a cephalometric analysis demonstrating a pattern of mandibular retrognathia. Oral examination was notable for flat and shallow palate, delayed eruption pattern, and impacted maxillary teeth. Subclinical and/or mild hearing loss was noted in 4 of 5 patients studied. The most common etiology was conductive, likely due to overcrowding of epitympanum which impedes the normal vibration of ossicles to sound. Paranasal sinus obliteration was noted in 5 of 6 patients. Computed tomography (CT) scan evaluation of craniofacial bones revealed bilaterally symmetric expansile lesions with predominant involvement of neural crest cell (NCC)-derived bones. Bilateral narrowing of facial nerve canals, particularly at the labyrinthine segment, was seen in 5 of 6 patients when compared to age-matched controls; 1 patient presented with progressive facial nerve palsy. Sagittal suture craniosynostosis was present in 5 of 6 patients-one of whom had a history of cranial reconstruction for pansynostosis in infancy. All patients demonstrated a significant degree of upper airway stenosis, as well as a more anterior hyoid bone displacement. Two patients had a diagnosis of obstructive sleep apnea. 18F-NaF Positron-emission tomography (PET)-CT revealed increased uptake associated with the skull base and gnathic bones in all patients. In conclusion, this first detailed systematic evaluation of the craniofacial phenotype of patients with JMC demonstrates a distinct and pronounced phenotype that predominantly affects the NCC-derived cranial bones indicating a critical role of PTH1R signaling in their development. These affects can result in significant disease-related morbidity, include hearing loss, nerve compression, craniosynostosis, dentoskeletal malocclusion, and airway compromise; all of which require close monitoring. Patients with Jansen metaphyseal chondrodysplasia (JMC) have severely shortened long bones. However, the effect on craniofacial bones has not been studied. We evaluated 6 individuals with JMC and noted a distinct facial appearance prompting a detailed analysis which revealed a pattern of premature cranial suture fusion, retrusion of the lower jaw, increased distance between the inner corners of eyelids, and low set ears. Oral examination demonstrated a flattened palate, delayed eruption pattern, impacted maxillary teeth, and structural dental abnormalities. Analysis of skull using CT revealed that the facial bones and cranial base are predominantly affected. Hearing was affected in 4 of 5 patients tested likely due to bony growth in the middle ear interfering with normal sound conduction. Comparison with age-matched controls revealed narrowing of the facial nerve canal in 5 patients-one of whom developed progressive facial nerve paralysis. All patients had significant upper airway narrowing-2 were diagnosed with obstructive sleep apnea. In summary, patients with JMC have a distinct facial appearance associated with hearing loss, facial nerve palsy, premature fusion of skull bones, delayed eruption of teeth, and airway stenosis. Patients and physicians should be aware of these issues for appropriate monitoring and treatment.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] A CONSTITUTIVELY ACTIVE MUTANT PTH-PTHRP RECEPTOR IN JANSEN-TYPE METAPHYSEAL CHONDRODYSPLASIA
    SCHIPANI, E
    KRUSE, K
    JUPPNER, H
    SCIENCE, 1995, 268 (5207) : 98 - 100
  • [22] Jansen-type metaphyseal chondrodysplasia: Examination of the PTH/PTHRP receptor by the RT-PCR.
    Yasuda, T
    Arakawa, K
    Minagawa, M
    Minamitani, K
    Niimi, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : S647 - S647
  • [23] A novel Mouse Model of Jansen's Metaphyseal Chondrodysplasia for analyzing disease mechanisms and candidate therapeutics
    Hoeppner, Jakob
    Firat, Damla
    Reyes, Monica
    Ramos-Torres, Karla
    Brugarolas, Pedro
    Yadav, Prem Swaroop
    Hanna, Patrick
    Wein, Marc
    Schipani, Ernestina
    Gardella, Thomas J.
    Jueppner, Harald
    JOURNAL OF BONE AND MINERAL RESEARCH, 2024, 39 : 386 - 386
  • [24] Hypophosphatemia with Elevations in Serum Fibroblast Growth Factor 23 in a Child with Jansen's Metaphyseal Chondrodysplasia
    Brown, Whitney W.
    Jueppner, Harald
    Langman, Craig B.
    Price, Heather
    Farrow, Emily G.
    White, Kenneth E.
    McCormick, Kenneth L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (01): : 17 - 20
  • [25] METAPHYSEAL DYSOSTOSIS OF JANSEN
    OZONOFF, MB
    RADIOLOGY, 1969, 93 (05) : 1047 - +
  • [26] METAPHYSEAL CHONDRODYSPLASIA CALCIFICANS
    VANCREVE.S
    KOZLOWSK.K
    ANNALES DE RADIOLOGIE, 1972, 15 (3-4) : 351 - &
  • [27] METAPHYSEAL CHONDRODYSPLASIA WITH THYMOLYMPHOPENIA
    CURRARIN.G
    SEMINARS IN ROENTGENOLOGY, 1973, 8 (02) : 228 - 228
  • [28] METAPHYSEAL AND SPONDYLOMETAPHYSEAL CHONDRODYSPLASIA
    KOZLOWSKI, K
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1976, (114) : 83 - 93
  • [29] Deletion of Zfp521 rescues the growth plate phenotype in a mouse model of Jansen metaphyseal chondrodysplasia
    Seriwatanachai, Dutmanee
    Densmore, Michael J.
    Sato, Tadatoshi
    Correa, Diego
    Neff, Lynn
    Baron, Roland
    Lanske, Beate
    FASEB JOURNAL, 2011, 25 (09): : 3057 - 3067
  • [30] Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia
    Schipani, E
    Langman, CB
    Parfitt, AM
    Jensen, GS
    Kikuchi, S
    Kooh, SW
    Cole, WG
    Juppner, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (10): : 708 - 714